Effects of a Novel Erectogenic Condom on Men and Women's Sexual Pleasure: Randomized Controlled Trial. Issue 9 (22nd November 2022)

• Record Type: Journal Article
• Authors: Gallo, M. F.; Nguyen, N. C.; Luff, A.; Luong, T. N.; Le, V. T.; Casterline, J.; Andridge, R.
• Is Part Of: Journal of sex research. Volume 59:Issue 9(2022)
• Page Start: 1133
• Page End: 1139
• Publication Date: 2022-11-22
• Subjects: Sexology -- Research -- Periodicals; Sex -- Periodicals; Psychiatry -- Periodicals; Sex; Psychiatry; 306.705
• DOI: 10.1080/00224499.2021.2024790
• Languages: English
• ISSNs: 0022-4499

Abstract

ABSTRACT: We tested whether CSD500 (Futura Medical; Guildford, UK), a novel condom containing erectogenic gel designed to increase penile firmness, penile size, and erection duration, results in greater sexual pleasure. In 2017–2020, we randomized heterosexual couples in Thanh Hoa, Vietnam to use CSD500 (N = 248) or standard condoms (N = 252) and followed them up for six months. Women completed the Quality of Sexual Experience (QSE) scale; men completed the QSE, Sexual Experience Questionnaire (SEX-Q), and 11 condom acceptability items. Female participants' mean age was 32.1 years ( SD = 0.24; range 21–46). QSE scores were higher among women ( B, 0.12; 95% CI, 0.03–0.21) and men ( B, 0.21; 95% CI, 0.08–0.35) in the CSD500 relative to the control arm. SEX-Q scores were higher among men in the CSD500 compared to the control arm ( B, 3.22; 95% CI, 1.53–4.91). Higher proportions of men in the CSD500 relative to the control arm reported the condom felt "natural" during sex (68.6% vs. 32.3%; p < .01) and that sex with the condom felt "a lot better" than condomless sex (15.5% vs. 5.3%; p < .01). Compared with standard condoms, CSD500 use was associated with higher reports of sexual pleasure and condom acceptability.